Versant Venture Management, LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1560009
San Francisco, CA
Position in GLUE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$52,323,831
-$16,396,701 QoQ
Shares Held
3,180,780
-27.4% QoQ
Ownership
3.73%
of shares outstanding
% of Portfolio
37.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Versant Venture Management, LLC holds $141,411,307 across 8 Biotechnology names. GLUE ranks #1 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
3,180,780 | $52,323,831 | |
| 2 | IPSC |
Century Therapeutics, Inc.
|
12,166,109 | $27,495,406 | |
| 3 | LENZ |
LENZ Therapeutics, Inc.
|
2,656,888 | $24,310,525 | |
| 4 | JBIO |
Jade Biosciences, Inc.
|
1,525,820 | $21,437,771 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
542,628 | $7,086,721 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
148,831 | $7,079,890 | |
| 7 | SKYE |
Skye Bioscience, Inc.
|
2,007,704 | $1,234,737 | |
| 8 | TPST |
Tempest Therapeutics, Inc.
|
269,772 | $442,426 |
All Filings in GLUE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,323,831 | 3,180,780 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $68,720,532 | 4,382,687 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $41,888,152 | 5,652,922 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $25,494,678 | 5,652,922 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $26,229,558 | 5,652,922 | Shares | Other | 2025-05-07 | |
| 2024-12-31 | $39,231,278 | 5,652,922 | Shares | Other | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||